The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-Choline
Open accessAbstract
Prostate cancer is biologically and clinically a heterogeneous disease that makes imaging evaluation challenging. The role of imaging in prostate cancer should include diagnosis, localization, and characterization (indolent vs. lethal) of the primary tumor, determination of extracapsular spread, guidance and evaluation of local therapy in organ-confined disease, staging of locoregional lymph nodes, detection of locally recurrent and metastatic disease in biochemical relapse, planning of radiation treatment, prediction and assessment of tumor response to salvage and systemic therapy, monitoring of active surveillance and definition of a trigger for definitive therapy, and prognostication of time to hormone refractoriness in castrate disease and overall survival. To address these tasks effectively, imaging needs to be tailored to the specific phases of the disease in a patient-specific, risk-adjusted manner. In this article, I review the preclinical and clinical evidence on the potential and emerging role of PET with the 3 most commonly studied radiotracers in prostate cancer, namely 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
SHREVE, P. D., Grossman, H. B., Gross, M. D., & Wahl, R. L. (1996) · Radiology · doi:10.1148/radiology.199.3.8638000 · Cited by 395
DeGrado, T. R., Coleman, R. E., Wang, S., BALDWIN, S. W., Orr, M. D., Robertson, C. N., Polascik, T. J., & Price, D. T. (2001) · PubMed · Cited by 368
Krause, B. J., Souvatzoglou, M., Tuncel, M., Herrmann, K., Buck, A. K., Praus, C., Schuster, T., Geinitz, H., Treiber, U., & Schwaiger, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0581-4 · Cited by 367
11C-acetate PET imaging in prostate cancer
Morris, M. J., & Scher, H. I. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0281-5 · Cited by 294
Beheshti, M., Imamovic, L., Broinger, G., Vali, R., Waldenberger, P., Stoiber, F., Nader, M., Gruy, B., Janetschek, G., & Langsteger, W. (2010) · Radiology · doi:10.1148/radiol.09090413 · Cited by 270
Liu, I. J., Zafar, M. B., Lai, Y.-H., Segall, G. M., & Terris, M. K. (2001) · Urology · doi:10.1016/s0090-4295(00)00896-7 · Cited by 267
Scattoni, V., Picchio, M., Suardi, N., Messa, C., Freschi, M., Roscigno, M., Da Pozzo, L., Bocciardi, A., Rigatti, P., & Fazio, F. (2007) · European Urology · doi:10.1016/j.eururo.2007.03.032 · Cited by 250
Farsad, M., Schiavina, R., Castellucci, P., Nanni, C., Corti, B., Martorana, G. E., Canini, R., Grigioni, W. F., Boschi, S., Marengo, M., et al. (2005) · PubMed · Cited by 247
The role of the androgen receptor in the development and progression of prostate cancer.
Jenster, G. W. (1999) · PubMed · Cited by 239
Yoshimoto, M., Waki, A., Yonekura, Y., Sadato, N., Murata, T., Omata, N., Takahashi, N., Welch, M. J., & Fujibayashi, Y. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00195-5 · Cited by 236
Mammalian hexokinases and their abnormal expression in cancer.
Smith, T. (2000) · PubMed · Cited by 224
Schöder, H., Herrmann, K., Gönen, M., Hricak, H., Eberhard, S., Scardino, P., Scher, H. I., & Larson, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0249 · Cited by 202
Morris, M. J., Akhurst, T., Osman, I., Nunez, R., Macapinlac, H., Siedlecki, K., Verbel, D., Schwartz, L., Larson, S. M., & Scher, H. I. (2002) · Urology · doi:10.1016/s0090-4295(02)01509-1 · Cited by 195
Heinisch, M., Dirisamer, A., Loidl, W., Stoiber, F., Gruy, B., Haim, S., & Langsteger, W. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0023-2 · Cited by 191
Seltzer, M., Barbaric, Z. L., Belldegrun, A. S., Naitoh, J., Dorey, F. J., Phelps, M. E., Gambhir, S. S., & Hoh, C. K. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68277-8 · Cited by 186
Beheshti, M., Vali, R., Waldenberger, P., Fitz, F., Nader, M., Hammer, J., Loidl, W., Pirich, C., Fogelman, I., & Langsteger, W. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0217-0 · Cited by 181
Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer
Scher, B., Seitz, M., Albinger, W., Tiling, R., Scherr, M., Becker, H.-C., Souvatzogluou, M., Gildehaus, F.-J., Wester, H.-J., & Dresel, S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0190-7 · Cited by 158
Vāvere, A. L., Kridel, S. J., Wheeler, F. B., & Lewis, J. S. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046672 · Cited by 154
The Increased Accumulation of [18F]Fluorodeoxyglucose in Untreated Prostate Cancer
Oyama, N., Akino, H., Suzuki, Y., Kanamaru, H., Sadato, N., Yonekura, Y., & Okada, K. (1999) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/29.12.623 · Cited by 152
Ponde, D. E., Dence, C. S., Oyama, N., Kim, J., Tai, Y., Laforest, R. A., Siegel, B. A., & Welch, M. J. (2007) · PubMed · Cited by 134
11C-acetate PET imaging of prostate cancer.
Oyama, N., Akino, H., Kanamaru, H., Suzuki, Y., Muramoto, S., Yonekura, Y., Sadato, N., Yamamoto, K., & Okada, K. (2002) · PubMed · Cited by 133
Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer
Apolo, A. B., Pandit-Taskar, N. D., & Morris, M. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.050658 · Cited by 128
Morris, M. J., Akhurst, T., Larson, S. M., Ditullio, M., Chu, E., Siedlecki, K. L., Verbel, D., Heller, G., Kelly, W. K., Slovin, S. F., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2034 · Cited by 118
FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation
Oyama, N., Akino, H., Suzuki, Y., Kanamaru, H., Ishida, H., Tanase, K., Sadato, N., Yonekura, Y., & Okada, K. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200109000-00004 · Cited by 118
In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer
Breeuwsma, A. J., Pruim, J., Jongen, M. M., Suurmeijer, A. J. H., Vaalburg, W., Nijman, R. J. M., & de Jong, I. J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1741-4 · Cited by 107
Effert, P. J., Beniers, A. J. M. C., Tamimi, Y., Handt, S., & Jakse, G. (2004) · PubMed · Cited by 101
Registration Methodology for Histological Sections and In Vivo Imaging of Human Prostate
Park, H., Piert, M., Khan, A. S., Shah, R. B., Hussain, H. K., Siddiqui, J., Chenevert, T. L., & Meyer, C. R. (2008) · Academic Radiology · doi:10.1016/j.acra.2008.01.022 · Cited by 98
Radiation dose estimates in humans for (11)C-acetate whole-body PET.
Seltzer, M., Jahan, S. A., Sparks, R. B., Stout, D. B., Satyamurthy, N., Dahlbom, M. L., Phelps, M. E., & Barrio, J. R. (2004) · PubMed · Cited by 95
The natural history of prostate cancer
Kessler, B., & Albertsen, P. C. (2003) · Urologic Clinics of North America · doi:10.1016/s0094-0143(02)00182-9 · Cited by 94
Stewart, G. D. (1994) · Oncology Reports · doi:10.3892/or_00000180 · Cited by 89
Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET
Jadvar, H. (2009) · Nature Reviews Urology · doi:10.1038/nrurol.2009.81 · Cited by 87
Self-citationComparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer
Pfannenberg, A. C., Rieger, A., Aschoff, P., Müller, M., Paulsen, F., Anastasiadis, A. G., Claussen, C., Bares, R., Schlemmer, H., & Eschmann, S. M. (2007) · Nuklearmedizin - NuclearMedicine · doi:10.1160/nukmed-0075 · Cited by 77
General Auditory Processes Contribute to Perceptual Accommodation of Coarticulation
Holt, L. L., & Kluender, K. R. (2000) · Phonetica · doi:10.1159/000028470 · Cited by 71
Pflug, B. R., Pecher, S., Brink, A. W., Nelson, J. B., & Foster, B. A. (2003) · The Prostate · doi:10.1002/pros.10297 · Cited by 63
Haberkorn, U., Bellemann, M. E., Altmann, A., Gerlach, L., Morr, I., Oberdorfer, F., Brix, G., Doll, J., Blatter, J., & KAICK, G. V. (1997) · PubMed · Cited by 51
C-11 ACETATE PET IMAGING OF PROSTATE CANCER
Oyama, N., Akino, H., Kanamaru, H., Sadato, N., Yonekura, Y., Yamamoto, K., & Okada, K. (1999) · The Journal of Urology · doi:10.1097/00005392-199904020-00570 · Cited by 50
Prostate cancer ? biology of metastasis and its clinical implications
Dong, J., Rinker-Schaeffer, C. W., Ichikawa, T., Barrett, J. C., & Isaacs, J. T. (1996) · World Journal of Urology · doi:10.1007/bf00186898 · Cited by 41
Glucose Metabolism of Human Prostate Cancer Mouse Xenografts
Jadvar, H., Li, X., Shahinian, A. H., Park, R. J.-H., Tohme, M. S., Pinski, J., & Conti, P. S. (2005) · Molecular Imaging · doi:10.1162/15353500200505118 · Cited by 41
Self-citation
Cited by
Targeting metabolic dysregulation for fibrosis therapy
Zhao, X., Kwan, J. Y. Y., Yip, K., Liu, P. P., & Liu, F.-F. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 513
Chen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
Ost, P., Bossi, A., Decaestecker, K., De Meerleer, G., Giannarini, G., Karnes, R. J., Roach, M., & Briganti, A. (2015) · European Urology · doi:10.1016/j.eururo.2014.09.004 · Cited by 349
The metabolic fate of acetate in cancer
Schug, Z. T., Vande Voorde, J., & Gottlieb, E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.87 · Cited by 331
Lecouvet, F. E., El Mouedden, J., Collette, L., Coche, E., Danse, E., Jamar, F., Machiels, J.-P., Vande Berg, B., Omoumi, P., & Tombal, B. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.020 · Cited by 303
Metadata
- Authors
- Jadvar, H.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2010-12-13
- Volume
- 52
- Issue
- 1
- Pages
- 81-89
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2073380728
- Cited by
- 290
- References
- 41
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.